tiprankstipranks
Trending News
More News >
Kaken Pharmaceutical Co Ltd (KKPCF)
OTHER OTC:KKPCF
US Market

Kaken Pharmaceutical Co (KKPCF) Ratios

Compare
4 Followers

Kaken Pharmaceutical Co Ratios

KKPCF's free cash flow for Q3 2025 was ¥0.61. For the 2025 fiscal year, KKPCF's free cash flow was decreased by ¥ and operating cash flow was ¥0.24. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
3.67 5.62 5.27 5.81 5.34
Quick Ratio
3.04 4.72 4.53 5.02 4.63
Cash Ratio
1.78 2.66 2.86 3.20 2.99
Solvency Ratio
0.44 0.39 0.27 0.45 0.58
Operating Cash Flow Ratio
0.98 0.14 0.44 0.70 0.68
Short-Term Operating Cash Flow Coverage
7.74 0.67 2.40 3.46 3.74
Net Current Asset Value
¥ 73.59B¥ 79.11B¥ 80.41B¥ 83.75B¥ 86.59B
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.02 0.02 0.02 0.02
Debt-to-Equity Ratio
0.03 0.03 0.03 0.03 0.03
Debt-to-Capital Ratio
0.02 0.03 0.03 0.03 0.03
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.25 1.19 1.22 1.20 1.20
Debt Service Coverage Ratio
4.26 2.79 2.38 3.12 3.84
Interest Coverage Ratio
751.29 559.59 470.47 1.00K 1.05K
Debt to Market Cap
0.02 0.03 0.03 0.03 0.02
Interest Debt Per Share
101.62 102.47 102.93 101.82 100.21
Net Debt to EBITDA
-2.28 -3.72 -5.27 -3.49 -2.98
Profitability Margins
Gross Profit Margin
61.96%53.49%54.20%54.68%54.56%
EBIT Margin
20.70%13.62%9.36%18.29%24.91%
EBITDA Margin
23.42%17.45%14.48%21.55%26.82%
Operating Profit Margin
22.37%13.20%10.96%22.44%23.72%
Pretax Profit Margin
20.67%13.60%9.34%18.26%24.88%
Net Profit Margin
14.83%11.14%7.45%12.56%17.88%
Continuous Operations Profit Margin
14.83%11.14%7.45%12.56%17.88%
Net Income Per EBT
71.75%81.92%79.80%68.77%71.85%
EBT Per EBIT
92.39%102.97%85.23%81.37%104.89%
Return on Assets (ROA)
7.32%4.68%3.27%5.78%8.21%
Return on Equity (ROE)
9.14%5.58%3.99%6.93%9.84%
Return on Capital Employed (ROCE)
13.14%6.23%5.50%11.68%12.52%
Return on Invested Capital (ROIC)
9.21%5.04%4.27%7.82%8.76%
Return on Tangible Assets
8.15%4.89%3.41%6.08%8.24%
Earnings Yield
8.15%6.13%3.92%6.46%8.01%
Efficiency Ratios
Receivables Turnover
4.44 3.03 3.79 3.75 3.65
Payables Turnover
4.30 4.72 5.38 5.80 3.98
Inventory Turnover
1.88 1.95 2.15 2.30 2.24
Fixed Asset Turnover
3.40 2.84 2.86 2.95 3.00
Asset Turnover
0.49 0.42 0.44 0.46 0.46
Working Capital Turnover Ratio
1.11 0.81 0.81 0.83 0.84
Cash Conversion Cycle
191.36 229.98 198.39 193.03 171.03
Days of Sales Outstanding
82.20 120.30 96.36 97.26 100.03
Days of Inventory Outstanding
194.07 187.02 169.93 158.68 162.79
Days of Payables Outstanding
84.91 77.34 67.91 62.91 91.79
Operating Cycle
276.27 307.31 266.29 255.94 262.83
Cash Flow Ratios
Operating Cash Flow Per Share
780.36 68.29 246.28 351.15 372.64
Free Cash Flow Per Share
671.92 10.86 187.56 265.39 313.40
CapEx Per Share
108.43 57.42 58.72 85.76 59.24
Free Cash Flow to Operating Cash Flow
0.86 0.16 0.76 0.76 0.84
Dividend Paid and CapEx Coverage Ratio
2.63 0.33 1.18 1.49 1.78
Capital Expenditure Coverage Ratio
7.20 1.19 4.19 4.09 6.29
Operating Cash Flow Coverage Ratio
7.74 0.67 2.40 3.46 3.74
Operating Cash Flow to Sales Ratio
0.32 0.04 0.13 0.18 0.19
Free Cash Flow Yield
14.99%0.31%5.08%6.82%7.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
12.26 16.30 25.52 15.47 12.48
Price-to-Sales (P/S) Ratio
1.82 1.82 1.90 1.94 2.23
Price-to-Book (P/B) Ratio
1.12 0.91 1.02 1.07 1.23
Price-to-Free Cash Flow (P/FCF) Ratio
6.67 319.11 19.70 14.66 13.83
Price-to-Operating Cash Flow Ratio
5.74 50.77 15.00 11.08 11.63
Price-to-Earnings Growth (PEG) Ratio
0.17 0.35 -0.60 -0.56 -0.42
Price-to-Fair Value
1.12 0.91 1.02 1.07 1.23
Enterprise Value Multiple
5.48 6.69 7.86 5.53 5.34
Enterprise Value
120.76B 84.06B 83.11B 90.56B 107.43B
EV to EBITDA
5.48 6.69 7.86 5.53 5.34
EV to Sales
1.28 1.17 1.14 1.19 1.43
EV to Free Cash Flow
4.71 205.02 11.79 8.98 8.88
EV to Operating Cash Flow
4.06 32.62 8.98 6.79 7.47
Tangible Book Value Per Share
3.49K 3.61K 3.46K 3.43K 3.51K
Shareholders’ Equity Per Share
4.00K 3.81K 3.63K 3.63K 3.53K
Tax and Other Ratios
Effective Tax Rate
0.28 0.18 0.20 0.31 0.28
Revenue Per Share
2.46K 1.91K 1.94K 2.00K 1.94K
Net Income Per Share
365.42 212.66 144.79 251.44 347.37
Tax Burden
0.72 0.82 0.80 0.69 0.72
Interest Burden
1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.20 0.17 0.22 0.11 0.09
SG&A to Revenue
0.00 <0.01 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
2.14 0.32 1.36 0.96 0.77
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis